To analyze the morbimortality of patients with peritrochanteric fractures treated with intramedullary rod and its relationship to the length of hospital stay, the time until surgery and the comorbidities of the patients. An observational, analytical and retrospective study was carried out through the evaluation of the medical records of 74 patients who underwent surgical treatment of peritrochanteric fractures with intramedullary proximal femoral rods from 2011 to 2014 in a hospital unit. The mean age at the moment of the fracture was 79.7 years, and the mean total hospitalization time was 16.7 days, with an average of 11.3 days until surgery and 5.4 days from surgery to discharge. The incidence of complications during hospitalization in the group aged ≥ 78.5 years was of 47.6%, while in the younger group it was of 19.4% ( = 0.013). The incidence of hospitalization complications in the group that underwent surgery more than 6 days after the fracture was significantly higher: 42.9% ( = 0.019). It was also observed that the incidence of complications during hospitalization was significantly associated with a surgical risk index ≥ 3 ( = 0.001) and diabetes mellitus ( = 0.001). Complications related to peritrochanteric fractures are significantly related with a high surgical risk index (grades 3 and 4), diabetes mellitus, age (> 78.5 years), and prolonged preoperative hospitalization (> 6 days).
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702023 | PMC |
http://dx.doi.org/10.1016/j.rbo.2018.04.006 | DOI Listing |
Chin J Traumatol
December 2024
Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. Electronic address:
Purpose: The management of irreducible, sagittally unstable peritrochanteric fractures presents a significant challenge due to the inability to achieve closed reduction using conventional techniques. This study introduces a novel minimally invasive technique leveraging the mechanical advantage principle with long, angled hemostatic clamps.
Methods: A retrospective review was performed on 16 patients who sustained sagittally unstable peritrochanteric fractures and underwent a percutaneous hemostatic clamp leverage reduction procedure.
BMJ Open
December 2024
Department of Orthopedics, Taleghani Hospital Research Development Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
J Orthop
May 2025
HCA Medical City Healthcare UNT-TCU GME (Denton) Program, Texas Bone and Joint, United States.
Background: We sought to investigate the relationship between peritrochanteric femur fracture (OTA 31A fractures) fixation and rates of peri-implant fracture, rates of transfusion, and the rates of increased dependence after secondary surgery for fracture for short cephalomedullary nails (SCMN), long cephalomedullary nails (LCMN), and plate and screw devices (PSD).
Methods: Multi center retrospective study involving data collected from 151 Level I-IV trauma centers using ICD9/10 and CPT codes for identification. 13,197 patients with peritrochanteric femur fractures between 2016 and 2021 were included in analysis.
Key Clinical Message: Lumbar facet fracture-dislocation is rare, often due to hyperflexion with rotational force. Abnormal scoliosis on radiography is a key sign, prompting further imaging. Facetectomy and laminectomy ensure safe reduction, while instrumented fusion is an effective surgical treatment.
View Article and Find Full Text PDFJ Orthop Trauma
October 2024
Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN; and.
Objectives: To evaluate tranexamic acid (TXA) when administered immediately on hospital presentation in patients with extracapsular peritrochanteric hip fractures to determine its effect on (1) transfusion rates, (2) estimated blood loss, and (3) complications.
Design: Prospective, double-blinded, randomized clinical trial.
Setting: Single-center, Level 1 trauma center.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!